Pfizer (PFE) Moves One Step Closer to Split as CEO Read Mulls Idea
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
Pfizer, Inc. (PFE) Tops Q4 EPS by 3c; Guides In-Line
January 29, 2013 7:01 AM ESTPfizer, Inc. (NYSE: PFE) reported Q4 EPS of $0.47, $0.03 better than the analyst estimate of $0.44. Revenue for the quarter came in at $15.1 billion versus the consensus estimate of $14.4 billion.
Pfizer, Inc. sees FY2013 EPS of $2.20-2.30, versus the consensus of $2.29. Pfizer, Inc. sees FY2013... More

